SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-20-000022
Filing Date
2020-04-30
Accepted
2020-04-30 07:27:13
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q q1202010-q.htm 10-Q 1092118
2 EXHIBIT 31.1 q12020exhibit311.htm EX-31.1 12818
3 EXHIBIT 31.2 q12020exhibit312.htm EX-31.2 12896
4 EXHIBIT 32.1 q12020exhibit321.htm EX-32.1 7541
5 EXHIBIT 32.2 q12020exhibit322.htm EX-32.2 7472
12 pipelinedecember2019a06.jpg GRAPHIC 141025
  Complete submission text file 0001367920-20-000022.txt   5298487

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20200331.xml EX-101.INS 955703
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20200331.xsd EX-101.SCH 37935
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20200331_cal.xml EX-101.CAL 66027
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20200331_def.xml EX-101.DEF 194598
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20200331_lab.xml EX-101.LAB 560420
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20200331_pre.xml EX-101.PRE 325576
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 20833141
SIC: 2834 Pharmaceutical Preparations